Ranitidine
- Product NDC
- 0615-8021
- 11-digit product format
- 006158021
- Labeler code
- 0615
- Product ID
- 0615-8021_9bedbb53-5f3e-4282-96bf-6293263dda25
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ranitidine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, LLC dba Vangard Labs
- Application
- ANDA078542
- Marketing category
- ANDA
- Marketing start
- 2008-11-19
- Marketing end
- 2021-04-30
- Substance
- RANITIDINE HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0615-8021-05 | 00615802105 | 15 TABLET, FILM COATED in 1 BLISTER PACK (0615-8021-05) | | 2008-11-19 | 0000-00-00 | No | No | Current |
| 0615-8021-30 | 00615802130 | 6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-8021-30) > 5 TABLET, FILM COATED in 1 BLISTER PACK | 6 blister pack | 2008-11-19 | 0000-00-00 | No | No | Current |
| 0615-8021-39 | 00615802139 | 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8021-39) | | 2008-11-19 | 0000-00-00 | No | No | Current |